Theralase Technologies, Inc.

Theralase Technologies, Inc.

Theralase Technologies, Inc.

Overview
Date Founded

1989

Headquarters

41 Hollinger Road, Toronto, ON, M4B 3G4, CAN

Type of Company

Public

Employees (Worldwide)

28

Industries

Medical Products & Equipment
Hospitals & Patient Services

Company Description

Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Medical Laser Technology (MLT), and Anti-Cancer Technology (ACT) segments. The MLT segment focuses on the company's medical laser business, which researches, develops, commercializes and manufactures lasers used by the ACT division. The ACT segment research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.

Contact Data
Trying to get in touch with decision makers at Theralase Technologies, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Interim Chief Executive Officer & Chief Scientific Officer

Chief Financial Officer

Director-Business Development

Director of Production & Service

Director of Marketing

Director-Investor Relations

Director-Clinical Education & Training

Director-Global Sales

Principal Investigator

Board of Directors

Chairman of the Board at Theralase Technologies, Inc.

Chief Financial Officer at Theralase Technologies, Inc.

Paths to Theralase Technologies, Inc.
Potential Connections via
Relationship Science
You
Theralase Technologies, Inc.
Recent Transactions
Details Hidden

Theralase Technologies, Inc. issued Up to CAD Units Consisting of Common Share and Warrants

Details Hidden

Theralase Technologies, Inc. issued CAD Units

Transaction Advisors
Auditor

Advised onTheralase Technologies, Inc. issued CAD Units

Underwriter

Advised onTheralase Technologies, Inc. issued CAD Units

Selling Group Member

Advised onTheralase Technologies, Inc. issued Up to CAD Units Consisting of Common Share and Warrants

Clients

Virginia Tech takes a hands-on, engaging approach to education, preparing scholars to be leaders in their fields and communities. As the commonwealth’s most comprehensive university and its leading research institution, Virginia Tech offers 215 undergraduate and graduate degree programs to more than 30,000 students and manages a research portfolio of more than $450 million. The university fulfills its land-grant mission of transforming knowledge to practice through technological leadership and by fueling economic growth and job creation locally, regionally, and across Virginia.

The Bell Telephone Co. of Canada engages in the provision of communications services. It includes residential, business, and wholesale customers with a range of solutions to all their communications needs, such as wireless, television, internet, home phone, and small business and enterprise communications services. The company was founded in 1880 and is located in Verdun, Canada.

The Scripps Research Institute (TSRI), one of the world's largest, private, non-profit research organizations, stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life. Over the last decades, the institute has established a lengthy track record of major contributions to the betterment of health and the human condition. The institute — which is located on campuses in La Jolla, California, and Jupiter, Florida — has become internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune diseases, cardiovascular diseases, virology, and synthetic vaccine development. Particularly significant is the institute's study of the basic structure and design of biological molecules; in this arena TSRI is among a handful of the world's leading centers. The institute’s educational programs are also top-rate. The Kellogg School of Science and Technology is currently ranked among the best in the nation in its fields of biology and chemistry. Rather than isolating faculty members, students, and laboratories into separate and distinct disciplines, as is generally prescribed in universities, a cooperative, collaborative spirit is encouraged and embraced. While the level of scientific investigation is intense, the atmosphere is collegial, relaxed, and informal. Technicians, postdoctoral fellows, graduate students, and administrative support staff all are considered part of the team and are given the latitude and responsibility to accomplish their tasks so as to serve the best interests of science. The pursuit of scientific excellence is paramount and all efforts are directed toward that end. The bulk of the institute's funding is derived from the National Institutes of Health and other federal agencies. In today's environment of increasing competition for shrinking federal dollars, however, collaborative industrial partnerships with leading pharmaceutical companies provide additional funding in several areas key to the organization's research objectives. The Scripps Research Institute's adherence to the highest scientific standards, emphasis on a multidisciplinary approach to problem solving, participation in the perpetuation of knowledge through education, and continual pursuit of research excellence provide an unparalleled scientific environment.

Key Stats and Financials As of 2018
Market Capitalization
$39.8M
Total Enterprise Value
$40.1M
Earnings Per Share
$-0.03
Revenue
$1.73M
Net Profit
$-3.36M
EBITDA
$-3.28M
EBITDAMargin
-189.4%
Total Debt
$0
Enterprise Value Sales
23.11x
TEVNet Income
-11.94x
Debt TEV
0x
Total Equity
$999K
Five Year Compounded Annual Growth Rate Of Revenue
7.58%
Three Year Compounded Annual Growth Rate Of Revenue
-3.76%
Suppliers
University Health Network Consumer Services | Toronto, Canada

University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Theralase Technologies, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Theralase Technologies, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Theralase Technologies, Inc..